172 related articles for article (PubMed ID: 24351818)
21. Biphasic drug release from film-coated tablets.
Ofori-Kwakye K; Fell JT
Int J Pharm; 2003 Jan; 250(2):431-40. PubMed ID: 12527169
[TBL] [Abstract][Full Text] [Related]
22. Preparation and in vitro evaluation of mebeverine HCl colon-targeted drug delivery system.
Abdullah GZ; Abdulkarim MF; Chitneni M; Mutee AF; Ameer OZ; Salman IM; Noor AM
Pharm Dev Technol; 2011 Aug; 16(4):331-42. PubMed ID: 20429815
[TBL] [Abstract][Full Text] [Related]
23. Delayed release film coating applications on oral solid dosage forms of proton pump inhibitors: case studies.
Missaghi S; Young C; Fegely K; Rajabi-Siahboomi AR
Drug Dev Ind Pharm; 2010 Feb; 36(2):180-9. PubMed ID: 20070183
[TBL] [Abstract][Full Text] [Related]
24. In-vitro evaluation of enteric coated insulin tablets containing absorption enhancer and enzyme inhibitor.
Wong CY; Martinez J; Carnagarin R; Dass CR
J Pharm Pharmacol; 2017 Mar; 69(3):285-294. PubMed ID: 28155991
[TBL] [Abstract][Full Text] [Related]
25. Chitosan and enteric polymer based once daily sustained release tablets of aceclofenac: in vitro and in vivo studies.
Mutalik S; Manoj K; Reddy MS; Kushtagi P; Usha AN; Anju P; Ranjith AK; Udupa N
AAPS PharmSciTech; 2008; 9(2):651-9. PubMed ID: 18500561
[TBL] [Abstract][Full Text] [Related]
26. Design and evaluation of enteric-coated tablets for rifampicin and isoniazid combinations.
Wang Y; Liu H; Liu K; Sun J; He Z
Pharm Dev Technol; 2013; 18(2):401-6. PubMed ID: 22339279
[TBL] [Abstract][Full Text] [Related]
27. Formulation and in vitro evaluation of Eudragit S-100 coated naproxen matrix tablets for colon-targeted drug delivery system.
Mehta R; Chawla A; Sharma P; Pawar P
J Adv Pharm Technol Res; 2013 Jan; 4(1):31-41. PubMed ID: 23662280
[TBL] [Abstract][Full Text] [Related]
28. Tablet formulation study of spray-dried sodium diclofenac enteric-coated microcapsules.
Lin SY; Kao YH
Pharm Res; 1991 Jul; 8(7):919-24. PubMed ID: 1924144
[TBL] [Abstract][Full Text] [Related]
29. Blend of cellulose ester and enteric polymers for delayed and enteric coating of core tablets of hydrophilic and hydrophobic drugs.
Ali SFB; Afrooz H; Hampel R; Mohamed EM; Bhattacharya R; Cook P; Khan MA; Rahman Z
Int J Pharm; 2019 Aug; 567():118462. PubMed ID: 31247274
[TBL] [Abstract][Full Text] [Related]
30. A comparative in vitro assessment of the drug release performance of pH-responsive polymers for ileo-colonic delivery.
Ibekwe VC; Fadda HM; Parsons GE; Basit AW
Int J Pharm; 2006 Feb; 308(1-2):52-60. PubMed ID: 16356670
[TBL] [Abstract][Full Text] [Related]
31. Regulating the pH of bicarbonate solutions without purging gases: Application to dissolution testing of enteric coated tablets, pellets and microparticles.
Scott N; Patel K; Sithole T; Xenofontos K; Mohylyuk V; Liu F
Int J Pharm; 2020 Jul; 585():119562. PubMed ID: 32565282
[TBL] [Abstract][Full Text] [Related]
32. OPTIMIZATION OF THE PREPARATION OF KOLLIDON SR-BASED AMIODARONE HYDROCHLORIDE TABLETS WITH SUSTAINED RELEASE.
Creţeanu A; Tàntaru G; Vieriu M; Panainte AD; Ochiuz L
Rev Med Chir Soc Med Nat Iasi; 2015; 119(4):1161-5. PubMed ID: 26793864
[TBL] [Abstract][Full Text] [Related]
33. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.
Sauer D; Zheng W; Coots LB; McGinity JW
Eur J Pharm Biopharm; 2007 Sep; 67(2):464-75. PubMed ID: 17451929
[TBL] [Abstract][Full Text] [Related]
34. Evolution of a physiological pH 6.8 bicarbonate buffer system: application to the dissolution testing of enteric coated products.
Liu F; Merchant HA; Kulkarni RP; Alkademi M; Basit AW
Eur J Pharm Biopharm; 2011 May; 78(1):151-7. PubMed ID: 21255647
[TBL] [Abstract][Full Text] [Related]
35. Characterization of 5-fluorouracil microspheres for colonic delivery.
Rahman Z; Kohli K; Khar RK; Ali M; Charoo NA; Shamsher AA
AAPS PharmSciTech; 2006 May; 7(2):E47. PubMed ID: 16796364
[TBL] [Abstract][Full Text] [Related]
36. Site Targeted Press Coated Delivery of Methylprednisolone Using Eudragit RS 100 and Chitosan for Treatment of Colitis.
Jagdale S; Chandekar A
Recent Pat Antiinfect Drug Discov; 2016; 11(1):32-43. PubMed ID: 26377799
[TBL] [Abstract][Full Text] [Related]
37. Determination of erythromycin and related substances in enteric-coated tablet formulations by reversed-phase liquid chromatography.
Wardrop J; Ficker D; Franklin S; Gorski RJ
J Pharm Sci; 2000 Sep; 89(9):1097-105. PubMed ID: 10944374
[TBL] [Abstract][Full Text] [Related]
38. Enteric polymers as acidifiers for the pH-independent sustained delivery of a weakly basic drug salt from coated pellets.
Körber M; Ciper M; Hoffart V; Pearnchob N; Walther M; Macrae RJ; Bodmeier R
Eur J Pharm Biopharm; 2011 Aug; 78(3):447-54. PubMed ID: 21443950
[TBL] [Abstract][Full Text] [Related]
39. A Novel Approach to Flurbiprofen Pulsatile Colonic Release: Formulation and Pharmacokinetics of Double-Compression-Coated Mini-Tablets.
Vemula SK
AAPS PharmSciTech; 2015 Dec; 16(6):1465-73. PubMed ID: 26017285
[TBL] [Abstract][Full Text] [Related]
40. Development of enteric-coated timed-release matrix tablets for colon targeting.
Alvarez-Fuentes J; Fernández-Arévalo M; González-Rodríguez ML; Cirri M; Mura P
J Drug Target; 2004; 12(9-10):607-12. PubMed ID: 15621686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
